Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Preston_Klassen
|
| gptkbp:developedBy |
FXR agonists
therapeutics for NASH |
| gptkbp:focusesOn |
liver diseases
metabolic diseases non-alcoholic steatohepatitis (NASH) |
| gptkbp:foundedBy |
gptkb:Ken_Song
|
| gptkbp:foundedYear |
2014
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Metacrine
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:status |
gptkb:public_company
|
| gptkbp:stockSymbol |
gptkb:MTCR
|
| gptkbp:website |
https://www.metacrine.com/
|
| gptkbp:bfsParent |
gptkb:Laura_Deming
|
| gptkbp:bfsLayer |
6
|